Hindustan Bio Sciences Ltd Management Discussions

Industry Structure and Developments

The Companys sales decreased compared with the previous year, primarily due to delays in the license renewal process in Sri Lanka. These delays affected the Companys ability to operate at full capacity, which consequently impacted revenue generation during the reporting period.

Segment-wise or product-wise performance : Details on the performance of the Company is mentioned in the Financial Statements of the Company.

Opportunities: Timely renewal of regulatory licences in Sri Lanka can enable the Company to restore full operational capacity and improve sales and revenue.

Threats: Further delays in regulatory approvals or licence renewals in Sri Lanka may disrupt operations, restrict capacity utilisation and adversely affect revenue.

The Board recognizes that reliance on timely regulatory approvals in key markets presents an operational risk. Any recurrence of delays in obtaining the necessary regulatory approvals in Sri Lanka could result in extended operational disruptions and reduced revenue.

The Company maintains internal control systems that are considered adequate and appropriate for the size, nature, and complexity of its operations. The Board continues to monitor the effectiveness of these controls to ensure that they remain appropriate to the Companys operational requirements

Our Company continues to have cordial relations with its employees and other stakeholders.

Key Financial Ratios: Refer Notes on accounts

The Company has complied with the appropriate accounting policies and has ensured that they have been applied consistently. There have been no deviations from the treatment prescribed in the Accounting Standards notified under Section 133 of the Companies Act, 2013.